| RS1396707186 |
LAMC3
|
Health Risk |
Pathogenic |
— |
| RS139671268 |
VLDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebellar ataxia, intellectual disability |
| RS139671810 |
SLC25A38
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS139673146 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic cardiomyopathy with wooly hair and keratoderma, Arrhythmogenic right ventricular dysplasia 8 |
| RS139673557 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS139674448 |
NDUFA9
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 26 |
| RS139675596 |
CPLANE1
|
Health Risk |
Pathogenic |
Joubert syndrome 17, Orofaciodigital syndrome type 6 |
| RS139675642 |
RFXAP
|
Health Risk |
Conflicting classifications of pathogenicity |
MHC class II deficiency, MHC class II deficiency |
| RS1396762844 |
TONSL
|
Health Risk |
Pathogenic |
— |
| RS1396766124 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia type I, Citrullinemia type I |
| RS139676674 |
SOS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, RASopathy |
| RS1396768987 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic cardiomyopathy with wooly hair and keratoderma, Arrhythmogenic right ventricular dysplasia 8 |
| RS1396769996 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS139677898 |
ABCG8
|
Health Risk |
Conflicting classifications of pathogenicity |
Sitosterolemia 1, Cardiovascular phenotype |
| RS139678787 |
MCPH1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1396789926 |
CEP164
|
Health Risk |
Likely pathogenic |
Nephronophthisis 15, Nephronophthisis 15 |
| RS139679441 |
HPS6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hermansky-Pudlak syndrome 6, Hermansky-Pudlak syndrome 6 |
| RS139679692 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS139679798 |
PNKP
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 12 |
| RS1396804493 |
EVC2
|
Health Risk |
Pathogenic |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS139680786 |
ATP6V0A2
|
Health Risk |
Conflicting classifications of pathogenicity |
ALG9 congenital disorder of glycosylation, ALG9 congenital disorder of glycosylation |
| RS1396816886 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS139681694 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS1396817932 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS139682740 |
TOP3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1396840386 |
MKKS
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS139684349 |
MIPEP
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome, Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome |
| RS1396843820 |
ALMS1
|
Health Risk |
Likely pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1396851699 |
ABCC9
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1O, Dilated cardiomyopathy 1O |
| RS139685237 |
CSF2RB
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS139685563 |
AGT
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal tubular dysgenesis, Renal tubular dysgenesis |
| RS139685583 |
NLRP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS139686090 |
FBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital contractural arachnodactyly, Connective tissue disorder |
| RS139686925 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS139687202 |
SPG11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 11, Amyotrophic lateral sclerosis |
| RS139687237 |
TACO1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS139687326 |
POMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2K, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS1396878326 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS139688032 |
DUOX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Thyroid dyshormonogenesis 6, Thyroid dyshormonogenesis 6 |
| RS1396885141 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrin deficiency, Citrin deficiency |
| RS139688774 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, Hereditary pancreatitis |
| RS1396889047 |
POLH
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum variant type, Xeroderma pigmentosum variant type |
| RS1396898151 |
DEPDC5
|
Health Risk |
Pathogenic |
Epilepsy, familial focal |
| RS1396898734 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1396898872 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS139690983 |
TOR1AIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2Y, Autosomal recessive limb-girdle muscular dystrophy type 2Y |
| RS1396912668 |
TERT
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, autosomal dominant 2 |
| RS139691540 |
MYH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Myopathy, proximal |
| RS139691722 |
XDH
|
Health Risk |
Conflicting classifications of pathogenicity |
Xanthinuria type II, Hereditary xanthinuria type 1 |
| RS139692347 |
MEFV
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial Mediterranean fever, Acute febrile neutrophilic dermatosis |
| RS139692564 |
KERA
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1396926041 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS139692779 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS139693694 |
NPHP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, NPHP3-related disorder |
| RS139694386 |
JMJD7;JMJD7-PLA2G4B;LOC112272587
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS139695003 |
F11
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary factor XI deficiency disease, Hereditary factor XI deficiency disease |
| RS139695699 |
ABCA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Interstitial lung disease due to ABCA3 deficiency, Hereditary pulmonary alveolar proteinosis |
| RS1396957653 |
CACNA1G
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1396963242 |
SLC4A11
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS139696516 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
LRP2-related disorder, LRP2-related disorder |
| RS139696600 |
TDRD7
|
Health Risk |
Conflicting classifications of pathogenicity |
TDRD7-related disorder, Inborn genetic diseases |
| RS139697290 |
THAP11
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1396973081 |
WRN
|
Health Risk |
Pathogenic |
Werner syndrome, Werner syndrome |
| RS139697646 |
PKLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyruvate kinase deficiency of red cells, Pyruvate kinase deficiency of red cells |
| RS139697733 |
PDE6A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS139698110 |
covers 10 genes, none of which curated to show dosage sensitivity
|
Health Risk |
Conflicting classifications of pathogenicity |
Lucey-Driscoll syndrome, Gilbert syndrome |
| RS1396994210 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS1397006934 |
MYH9
|
Health Risk |
Likely pathogenic |
Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss |
| RS139701269 |
STAT3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyper-IgE recurrent infection syndrome 1, autosomal dominant |
| RS139701867 |
POMGNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS1397027035 |
AP4M1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 50, Hereditary spastic paraplegia 50 |
| RS1397029418 |
MYO7A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1397030516 |
PLA2G6
|
Health Risk |
Pathogenic |
Infantile neuroaxonal dystrophy, Infantile neuroaxonal dystrophy |
| RS139703319 |
TRIP12
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Clark-Baraitser syndrome |
| RS139703788 |
ELP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary sensory and autonomic neuropathy, Familial dysautonomia |
| RS139703919 |
MXRA5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1397045479 |
VPS13D
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, VPS13D-related disorder |
| RS139705205 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS139705387 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS139705992 |
CSF3R
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive severe congenital neutropenia due to CSF3R deficiency, Autosomal recessive severe congenital neutropenia due to CSF3R deficiency |
| RS139706467 |
TDRD7
|
Health Risk |
Conflicting classifications of pathogenicity |
Cataract 36, Cataract 36 |
| RS1397066983 |
ALDH7A1
|
Health Risk |
Pathogenic |
Pyridoxine-dependent epilepsy, Pyridoxine-dependent epilepsy |
| RS1397068742 |
HNRNPK
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS139707740 |
FGFR3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS139708286 |
SPR
|
Health Risk |
Conflicting classifications of pathogenicity |
Dopa-responsive dystonia due to sepiapterin reductase deficiency, Dystonic disorder |
| RS1397083296 |
ATP7B
|
Health Risk |
Pathogenic |
Wilson disease, Wilson disease |
| RS1397086223 |
CLN3
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS1397090015 |
KNL1
|
Health Risk |
Likely pathogenic |
— |
| RS1397090654 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiomyopathy |
| RS139709507 |
VPS33B
|
Health Risk |
Conflicting classifications of pathogenicity |
Arthrogryposis, renal dysfunction |
| RS1397098803 |
CPT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyl transferase II deficiency |
| RS1397110438 |
MEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 1 |
| RS1397111065 |
LMX1B
|
Health Risk |
Pathogenic |
— |
| RS139712739 |
HNF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 3, Maturity-onset diabetes of the young |
| RS139713073 |
LAMA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome, Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome |
| RS139714761 |
IFIH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Singleton-Merten syndrome 1, Aicardi-Goutieres syndrome 7 |
| RS139715157 |
UNC45B
|
Health Risk |
Pathogenic |
Myopathy, Myofibrillar myopathy 11 |
| RS1397152875 |
GALC
|
Health Risk |
Likely pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1397154022 |
BLTP1
|
Health Risk |
Likely pathogenic |
Alkuraya-Kucinskas syndrome, Alkuraya-Kucinskas syndrome |
| RS139716296 |
PMM2
|
Health Risk |
Pathogenic |
PMM2-congenital disorder of glycosylation, Intellectual disability |